LCD L38582: MolDX: Molecular Testing for Solid Organ Allograft Rejection — CGS
Policy LCD-L38582 · Transplantation
New molecular testing coverage impacts organ transplant billing.
Code intelligence
0320U reimbursement alerts
Policy changes, MAC LCD updates, and CMS guidance matched to code 0320U.
Elevated code risk
Signal breakdown
17 shown · 17 total in platform
Risk: Elevated
0
Critical
0%
13
High
76%
4
Routine
24%
0
Low
0%
New this month
—
alerts added in last 30 days
Effective soon
—
no upcoming deadlines
High
LCD L36021: MolDX: Molecular Diagnostic Tests (MDT) — CGS
Policy LCD-L36021 · Clinical Laboratory
New MolDX policy effective in 2025 may alter billing processes.
LCD L36256: MolDX: Molecular Diagnostic Tests (MDT) — Noridian
Policy LCD-L36256 · Clinical Laboratory
New molecular diagnostics policy may impact billing processes.
LCD L38629: MolDX: Molecular Testing for Solid Organ Allograft Rejection — Noridian
Policy LCD-L38629 · Multi-specialty
New LCD impacts molecular testing billing practices.
LCD L38671: MolDX: Molecular Testing for Solid Organ Allograft Rejection — Noridian
Policy LCD-L38671 · Transplantation
New LCD for organ rejection testing impacts billing compliance.
LCD L35160: MolDX: Molecular Diagnostic Tests (MDT) — Noridian
Policy LCD-L35160 · Clinical Laboratory
New MolDX guidelines may alter MDT billing processes.
Proposed LCD DL40140: MolDX: Molecular Testing for Solid Organ Allograft Rejection — CGS
Policy LCD-DL40140 · Clinical Laboratory
Impact of new LCD on organ transplant testing reimbursement.
LCD L38568: MolDX: Molecular Testing for Solid Organ Allograft Rejection — Palmetto GBA
Policy LCD-L38568 · Multi-specialty
New LCD for molecular testing impacts billing practices.
LCD L40140: MolDX: Molecular Testing for Solid Organ Allograft Rejection — CGS
Policy LCD-L40140 · Clinical Laboratory
CGS finalizes molecular allograft rejection testing coverage for KY & OH.
Proposed LCD DL40058: MolDX: Molecular Testing for Solid Organ Allograft Rejection — Palmetto GBA
Policy LCD-DL40058 · Clinical Laboratory
New LCD may change billing for organ transplant tests.
Proposed LCD DL40060: MolDX: Molecular Testing for Solid Organ Allograft Rejection — Noridian
Policy LCD-DL40060 · Nephrology
New LCD could reshape billing for organ transplant tests.
Proposed LCD DL40062: MolDX: Molecular Testing for Solid Organ Allograft Rejection — Noridian
Policy LCD-DL40062 · Multi-specialty
Impact of LCD on organ transplant testing reimbursements.
Proposed LCD DL40249: MolDX: Molecular Testing for Solid Organ Allograft Rejection — WPS
Policy LCD-DL40249 · Transplantation
New LCD could impact solid organ testing reimbursements.
LCD L40249: MolDX: Molecular Testing for Solid Organ Allograft Rejection — WPS
Policy LCD-L40249 · Clinical Laboratory
WPS finalizes molecular allograft rejection testing coverage (eff. 8/30/26)
LCD L40060: MolDX: Molecular Testing for Solid Organ Allograft Rejection — Noridian
Policy LCD-L40060 · Clinical Laboratory
Noridian finalizes molecular allograft rejection testing coverage (eff. 8/30/26)
LCD L40062: MolDX: Molecular Testing for Solid Organ Allograft Rejection — Noridian
Policy LCD-L40062 · Clinical Laboratory
Noridian finalizes coverage for molecular allograft rejection testing, eff. 8/30
LCD L40058: MolDX: Molecular Testing for Solid Organ Allograft Rejection — Palmetto GBA
Policy LCD-L40058 · Clinical Laboratory
Palmetto MolDX LCD for allograft rejection molecular testing eff. 8/30/26
Audit documentation
Building an audit file that includes 0320U?
The Tripwire Audit Pack exports 12 months of single-specialty policy-change history — every alert with a link to its government source document, as a formatted PDF for compliance distribution plus a machine-readable CSV. Delivered automatically after payment. No account, no call.
See audit packs — $349One-time purchase · not a subscription